Frontiers

UPFRONT Winter 2014 

Tags:

A Summer of Progress
A beautiful autumn followed a summer of successes at the OSUCCC – James.



MICHAEL A. CALIGIURI, MD
DIRECTOR, COMPREHENSIVE CANCER CENTER CHIEF EXECUTIVE OFFICER, JAMES CANCER HOSPITAL AND SOLOVE RESEARCH INSTITUTE THE OHIO STATE UNIVERSITY, JOHN L. MARAKAS NATIONWIDE INSURANCE ENTERPRISE FOUNDATION CHAIR IN CANCER RESEARCH

Our fifth annual Pelotonia bicycling event, held in August, attracted a record 6,723 riders from 41 states and nine countries, plus 3,451 virtual riders and more than 2,300 volunteers.

Every dollar raised by Pelotonia supports research at the OSUCCC – James. That work is furthered by outstanding recruits such as Raphael Pollock, MD, PhD, whom we recruited from MD Anderson Cancer Center to serve as director of the Division of Surgical Oncology and as chief of surgical services at the OSUCCC – James.

This issue of Frontiers includes a story about Vinay Puduvalli, MBBS, our new director of the Division of Neuro-Oncology. Dr. Puduvalli specializes in treating gliomas and other primary brain tumors. His experience and success in patient care, clinical trials, and basic and translational research make him an outstanding addition to our faculty.

Read here also about Matthew Ringel, MD, and his collaborators who have received an $11.3 million, five-year renewal of their Program Project Grant from the National Cancer Institute (NCI) to help meet the growing challenge of thyroid cancer.  The NCI has also awarded Matt a prestigious Specialized Program of Research Excellence (SPORE) grant for thyroid cancer.  This is a collaborative grant with MD Anderson Cancer Center. The SPORE is centered at Ohio State with Matt as principal investigator. This issue’s cover story describes progress by OSUCCC – James researchers in understanding inflammation and cancer, work that could lead to new approaches for preventing and treating malignancies.

In August, we mourned the passing of Bertha A. Bouroncle, MD, a pioneer in Ohio State cancer research. In 1958, Dr. Bouroncle first identified the malignancy now called hairy cell leukemia and later helped develop an effective therapy for it. With her passing we lost a great scholar and friend and a caring physician.

The caring and commitment of our nursing team was recently recognized by the American Nurses Credentialing Center with their highly prestigious Magnet® designation. The award recognizes quality patient care, nursing excellence and innovations in professional nursing practice. Only 392 hospitals out of more than 6,000 across the United States have earned Magnet status. This was a well-deserved honor for all our James nurses, who work daily toward achieving our vision of a cancer-free world.


​​

 
16-Jan-14
6  Comments  |  Trackback Url  | 0  Link to this post

Bookmark this post with:        
 

Links to this post

Comments


Kayden  commented on  Thursday, February 06, 2014  7:45 AM 
It's a pleasure to find such ranatoility in an answer. Welcome to the debate.


life insurance  commented on  Monday, February 10, 2014  11:09 AM 
Great insight. Relieved I'm on the same side as you.


best online cialis to buy  commented on  Sunday, February 16, 2014  9:41 PM 
I'm impressed by your writing. Are you a professional or just very knowledgeable?


www.insurecaronline.com  commented on  Wednesday, February 26, 2014  1:10 AM 
This was so helpful and easy! Do you have any articles on rehab?


play free slots  commented on  Tuesday, April 08, 2014  3:41 AM 
Thanky Thanky for all this good information!


cheap car insurance quotes  commented on  Sunday, April 13, 2014  8:34 PM 
I really needed to find this info, thank God!

Name *:
URL:
Email:
Comments:

CAPTCHA Image Validation